Northern Trust Corp Care Dx, Inc. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

A detailed history of Northern Trust Corp transactions in Care Dx, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 421,904 shares of CDNA stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
421,904
Previous 439,032 3.9%
Holding current value
$12.6 Million
Previous $4.65 Million 40.93%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$7.56 - $16.15 $129,487 - $276,617
-17,128 Reduced 3.9%
421,904 $6.55 Million
Q1 2024

May 14, 2024
SELL
$7.96 - $12.37 $62,095 - $96,498
-7,801 Reduced 1.75%
439,032 $4.65 Million
Q4 2023

Feb 13, 2024
SELL
$4.9 - $12.86 $226,674 - $594,903
-46,260 Reduced 9.38%
446,833 $5.36 Million
Q3 2023

Nov 13, 2023
BUY
$7.0 - $11.26 $32,732 - $52,651
4,676 Added 0.96%
493,093 $3.45 Million
Q2 2023

Aug 11, 2023
BUY
$7.61 - $9.46 $127,102 - $158,000
16,702 Added 3.54%
488,417 $4.15 Million
Q1 2023

May 15, 2023
BUY
$8.83 - $17.61 $54,145 - $107,984
6,132 Added 1.32%
471,715 $4.31 Million
Q4 2022

Feb 13, 2023
BUY
$10.88 - $20.05 $11,380 - $20,972
1,046 Added 0.23%
465,583 $5.31 Million
Q3 2022

Nov 14, 2022
SELL
$16.06 - $26.39 $2.95 Million - $4.85 Million
-183,685 Reduced 28.34%
464,537 $7.91 Million
Q2 2022

Aug 12, 2022
SELL
$20.49 - $39.72 $469,282 - $909,707
-22,903 Reduced 3.41%
648,222 $13.9 Million
Q1 2022

May 13, 2022
SELL
$28.19 - $46.6 $211,481 - $349,593
-7,502 Reduced 1.11%
671,125 $24.8 Million
Q4 2021

Feb 08, 2022
SELL
$41.2 - $73.6 $1.15 Million - $2.06 Million
-27,967 Reduced 3.96%
678,627 $30.9 Million
Q3 2021

Nov 15, 2021
SELL
$59.15 - $91.99 $926,052 - $1.44 Million
-15,656 Reduced 2.17%
706,594 $44.8 Million
Q2 2021

Aug 13, 2021
SELL
$63.02 - $95.11 $382,846 - $577,793
-6,075 Reduced 0.83%
722,250 $66.1 Million
Q1 2021

May 12, 2021
SELL
$57.62 - $95.6 $154,421 - $256,207
-2,680 Reduced 0.37%
728,325 $49.6 Million
Q4 2020

Feb 11, 2021
SELL
$41.43 - $77.09 $2.56 Million - $4.77 Million
-61,883 Reduced 7.8%
731,005 $53 Million
Q3 2020

Nov 16, 2020
BUY
$30.88 - $37.94 $1.44 Million - $1.77 Million
46,726 Added 6.26%
792,888 $30.1 Million
Q2 2020

Aug 14, 2020
BUY
$18.95 - $35.43 $1.75 Million - $3.28 Million
92,438 Added 14.14%
746,162 $26.4 Million
Q1 2020

May 14, 2020
BUY
$13.94 - $28.25 $2.14 Million - $4.33 Million
153,226 Added 30.61%
653,724 $14.3 Million
Q4 2019

Feb 14, 2020
SELL
$19.24 - $28.41 $905,780 - $1.34 Million
-47,078 Reduced 8.6%
500,498 $10.8 Million
Q3 2019

Nov 13, 2019
BUY
$20.03 - $40.08 $1.77 Million - $3.53 Million
88,181 Added 19.2%
547,576 $12.4 Million
Q2 2019

Aug 13, 2019
BUY
$25.78 - $39.77 $321,038 - $495,255
12,453 Added 2.79%
459,395 $16.5 Million
Q1 2019

May 13, 2019
BUY
$22.09 - $39.21 $170,335 - $302,348
7,711 Added 1.76%
446,942 $14.1 Million
Q4 2018

Feb 12, 2019
BUY
$19.89 - $30.02 $490,825 - $740,803
24,677 Added 5.95%
439,231 $11 Million
Q3 2018

Nov 14, 2018
BUY
$12.1 - $28.85 $545,347 - $1.3 Million
45,070 Added 12.2%
414,554 $12 Million
Q2 2018

Sep 18, 2018
BUY
$7.93 - $15.79 $108,006 - $215,059
13,620 Added 3.83%
369,484 $4.52 Million
Q2 2018

Aug 14, 2018
BUY
$7.93 - $15.79 $2.47 Million - $4.92 Million
311,721 Added 706.16%
355,864 $4.36 Million
Q4 2017

Feb 14, 2018
BUY
$3.98 - $7.37 $49,730 - $92,088
12,495 Added 39.48%
44,143 $324,000
Q3 2017

Nov 13, 2017
BUY
$1.33 - $4.12 $42,091 - $130,389
31,648
31,648 $117,000

Others Institutions Holding CDNA

# of Institutions
157
Shares Held
53.5M
Call Options Held
60.8K
Put Options Held
34.9K
View Full List

About CareDx, Inc.

CDNA Quotes by TradingView
  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.59B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email